NASDAQ
Knight Therapeutics Inc. (KHTRF) has a free cash flow growth of 10.19% as of Friday, May 29, 2026. This represents a 100.27% increase compared to its 12-month average of -3799.02%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.